Stock Research for TEVA


Featured Broker: Ally Invest

Get the due diligence for another stock.


TEVA Stock Chart & Research Data

The TEVA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the TEVA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


TEVA Due diligence Resources & Stock Charts

The TEVA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View TEVA Detailed Price Forecast - CNN Money CNN View TEVA Detailed Summary - Google Finance
Yahoo View TEVA Detailed Summary - Yahoo! Finance Zacks View TEVA Stock Research & Analysis -

Stock Analysis

TradeIdeas View TEVA Trends & Analysis - Trade-Ideas Barrons View TEVA Major Holders - Barrons
NASDAQ View TEVA Call Transcripts - NASDAQ Seeking View TEVA Breaking News & Analysis - Seeking Alpha
Spotlight View TEVA Annual Report - OTC Report View TEVA OTC Short Report -
TradeKing View TEVA Fundamentals - TradeKing Charts View TEVA SEC Filings - Bar Chart
WSJ View Historical Prices for TEVA - The WSJ Morningstar View Performance/Total Return for TEVA - Morningstar
MarketWatch View the Analyst Estimates for TEVA - MarketWatch CNBC View the Earnings History for TEVA - CNBC
StockMarketWatch View the TEVA Earnings - StockMarketWatch MacroAxis View TEVA Buy or Sell Recommendations - MacroAxis
Bullish View the TEVA Bullish Patterns - American Bulls Short Pains View TEVA Short Pain Metrics -

Social Media Mentions

StockTwits View TEVA Stock Mentions - StockTwits PennyStocks View TEVA Stock Mentions - PennyStockTweets
Twitter View TEVA Stock Mentions - Twitter Invest Hub View TEVA Investment Forum News - Investor Hub
Yahoo View TEVA Stock Mentions - Yahoo! Message Board Seeking Alpha View TEVA Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for TEVA - Insider Cow View Insider Transactions for TEVA - Insider Cow
CNBC View TEVA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for TEVA - OTC Markets
Yahoo View Insider Transactions for TEVA - Yahoo! Finance NASDAQ View Institutional Holdings for TEVA - NASDAQ

Stock Charts

FinViz View TEVA Stock Insight & Charts - StockCharts View TEVA Investment Charts -
BarChart View TEVA Stock Overview & Charts - BarChart Trading View View TEVA User Generated Charts - Trading View

Latest Financial News for TEVA

Oklahoma top court clears way for Purdue, J&J, Teva to face opioid trial
Posted on Monday March 25, 2019

The Oklahoma Supreme Court's decision was a win for the state's attorney general, whose case is set to be the first to face trial of roughly 2,000 lawsuits nationally seeking to hold opioid manufacturers responsible for contributing to the epidemic. Oklahoma Attorney General Mike Hunter's 2017 lawsuit accuses Purdue, Johnson & Johnson & Teva Pharmaceutical Industries Ltd of engaging in deceptive marketing that downplayed the risks of addiction associated with opioid pain drugs while overstating their benefits. The trial delay bid came as Purdue, owned by members of the wealthy Sackler family, was exploring filing for Chapter 11 bankruptcy protection to address potential liabilities stemming from the lawsuits, people familiar with the matter have told Reuters.

Why Wall Street Has Mixed Opinions on Teva Pharmaceutical
Posted on Monday March 25, 2019

How Generic Pharmaceutical Stocks Are Positioned this MonthAnalysts’ recommendations and target prices Wall Street analysts expect an upside potential of 24.43% for Teva Pharmaceutical (TEVA), based on the company’s closing price on March 22. In

Teva Announces Launch of a Generic Version of EXJADE® (deferasirox) Tablets For Oral Suspension in the United States
Posted on Friday March 22, 2019

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of EXJADE®1 (deferasirox) Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg, in the U.S. Deferasirox Tablets for Oral Suspension are an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions in patients two years of age and older.

Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision
Posted on Wednesday March 20, 2019

The FDA will provide its decision on Jazz's (JAZZ) candidate, solriamfetol, for excessive daytime sleepiness with narcolepsy on Wednesday.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.